1. Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice. Issue 3 (April 2018) Authors: Aitken, Amelia S.; Roy, Dominic G.; Martin, Nikolas T.; Sad, Subash; Bell, John C.; Bourgeois-Daigneault, Marie-Claude Journal: Journal of immunotherapy Issue: Volume 41:Issue 3(2018:Apr.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment. Issue 1 (December 2016) Authors: Bourgeois-Daigneault, Marie-Claude; St-Germain, Lauren; Roy, Dominic; Pelin, Adrian; Aitken, Amelia; Arulanandam, Rozanne; Falls, Theresa; Garcia, Vanessa; Diallo, Jean-Simon; Bell, John Journal: Breast cancer research Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference. Issue 1 (19th June 2018) Authors: Bastin, Donald; Aitken, Amelia S.; Pelin, Adrian; Pikor, Larissa A.; Crupi, Mathieu J. F.; Huh, Michael S.; Bourgeois-Daigneault, Marie-Claude; Bell, John C.; Ilkow, Carolina S. Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity. Issue 2 (19th February 2021) Authors: Jenner, Adrianne L; Cassidy, Tyler; Belaid, Katia; Bourgeois-Daigneault, Marie-Claude; Craig, Morgan Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation. (3rd April 2017) Authors: Veinalde, Rūta; Grossardt, Christian; Hartmann, Laura; Bourgeois-Daigneault, Marie-Claude; Bell, John C.; Jäger, Dirk; von Kalle, Christof; Ungerechts, Guy; Engeland, Christine E. Journal: Oncoimmunology Issue: Volume 6:Number 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pre-surgical oncolytic virotherapy improves breast cancer outcomes. (2nd November 2019) Authors: Mullins-Dansereau, Victor; Petrazzo, Grégory; Geoffroy, Karen; Béland, Delphine; Bourgeois-Daigneault, Marie-Claude Journal: Oncoimmunology Issue: Volume 8:Number 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The pros and cons of interferons for oncolytic virotherapy. (December 2020) Authors: Geoffroy, Karen; Bourgeois-Daigneault, Marie-Claude Journal: Cytokine & growth factor reviews Issue: Volume 56(2020) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗